|
Annese V, Barcia C, Ros-Bernal F, Gómez A, Ros CM, De Pablos V, Fernández-Villalba E, De Stefano ME, Herrero MT. Evidence of oligodendrogliosis in MPTP-induced Parkinsonism. Neuropathol Appl Neurobiol. 2012 Mar 23. doi: 10.1111/j.1365-2990.2012.01271.x. [Epub ahead of print] PubMed PMID: 22443457.
AÑO: 2012; IF: 4.837
|
22443457
|
Barcia C, Ros CM, Annese V, Carrillo-de Sauvage MA, Ros-Bernal F, Gómez A, Yuste JE, Campuzano CM, de Pablos V, Fernandez-Villalba E, Herrero MT. ROCK/Cdc42-mediated microglial motility and gliapse formation lead to phagocytosis of degenerating dopaminergic neurons in vivo. Sci Rep. 2012;2:809. doi: 10.1038/srep00809. Epub 2012 Nov 8. PubMed PMID: 23139861; PubMed Central PMCID: PMC3492875.
AÑO: 2012; IF: 2.927
|
|
Nombela C, Pedreño-Molina JL, Ros-Bernal F, Molina-Vilaplana J, Fdez-Villalba E, López-Coronado J, Herrero MT. Dopamine modulation affects the performance of parkinsonian patients in a precision motor task measured by an antropomorphic device. Hum Mov Sci. 2012 Jun;31(3):730-42. doi: 10.1016/j.humov.2011.07.012. Epub 2012 Mar 11. PubMed PMID: 22414696.
AÑO: 2012; IF: 2.064
|
|
Carrillo-de Sauvage MA, Gómez A, Ros CM, Ros-Bernal F, Martín ED, Perez-Vallés A, Gallego-Sanchez JM, Fernández-Villalba E, Barcia C Sr, Barcia C Jr, Herrero MT. CCL2-expressing astrocytes mediate the extravasation of T lymphocytes in the brain. Evidence from patients with glioma and experimental models in vivo. PLoS One. 2012;7(2):e30762. doi: 10.1371/journal.pone.0030762. Epub 2012 Feb 2. PubMed PMID: 22319587; PubMed Central PMCID: PMC3271104.
AÑO: 2012; IF: 3.73
|
|
Nombela C, Bustillo PJ, Castell PF, Sanchez L, Medina V, Herrero MT. Cognitive rehabilitation in Parkinson's disease: evidence from neuroimaging. Front Neurol. 2011 Dec 22;2:82. doi: 10.3389/fneur.2011.00082. eCollection 2011. PubMed PMID: 22203816; PubMed Central PMCID: PMC3244758.
AÑO: 2011
|